Amplius Wealth Advisors, LLC Acelrx Pharmaceuticals Inc Transaction History

Amplius Wealth Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 09, 2022	SELL	$0.28 - $0.61 $252 - $549	-900 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$0.49 - $1.02 $441 - $918	900 New	900 $0

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Amplius Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Amplius Wealth Advisors, LLC with notifications on news.